# A randomized phase 2 study of an individualized neoantigen-targeting immunotherapy in patients with newly diagnosed metastatic microsatellite stable colorectal cancer (MSS-CRC).

Article · Joel Randolph Hecht, Alexander I. Spira, Anthony V. Nguyen, Lyudmyla Derby Berim, Alexander Starodub, Meredith S. Pelster, David H. Gallinson, Anup Kasi, Matthew J. Reilley, Agustin Pimentel, Ki Young Chung, Fa-Chyi Lee, Brian A. Chauder, Kyounghwa Bae, Desiree Schneck, Andrew R. Allen, Karin U. Jooss, Andrew R. Ferguson, Joseph Thaddeus Beck

- Archive id: doi:10.1200/jco.2025.43.4_suppl.lba13
- Published: 2025-01-27
- Venue: Journal of Clinical Oncology
- DOI: https://doi.org/10.1200/jco.2025.43.4_suppl.lba13
- Citations: 12
- Source URL: https://doi.org/10.1200/jco.2025.43.4_suppl.lba13
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [mRNA Therapeutics & Cancer Vaccines](https://space-kitty.com/topics/mrna-cancer-vaccines)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.